Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Freddie C Hamdy

Showing results (1-10 of 270) with videos related to

Pageof 27
Sort By:
European Urology|September 11, 2007
Screening for prostate cancer: an updateRichard J Bryant, Freddie C Hamdy
Expert Review of Anticancer Therapy|July 13, 2002
Staging in prostate cancerBeverley A Wilkinson, Freddie C Hamdy
Cancer Treatment Reviews|June 6, 2003
Early diagnosis and surgical management of prostate cancerKate D Linton, Freddie C Hamdy
Current Urology Reports|April 27, 2007
The spectrum of prostate cancer care: from curative intent to palliationAsed S M Ali, Freddie C Hamdy
Cancer Research|March 27, 2012
Mre11-dependent degradation of stalled DNA replication forks is prevented by BRCA2 and PARP1Songmin Ying, Freddie C Hamdy, Thomas Helleday
Future Oncology (London, England)|February 12, 2010
Targeting chemotherapy to advanced bladder cancer patients most likely to benefitJames W F Catto, Freddie C Hamdy
European Urology Focus|November 4, 2017
Reducing Mortality in the Ageing Patient: Treatment of the Primary Tumour Is Not NecessaryAlastair D Lamb, Simon F Brewster, Freddie C Hamdy
Acta Oncologica (Stockholm, Sweden)|May 25, 2011
Curative radiation therapy in prostate cancerUlrika Harmenberg, Freddie C Hamdy, Anders Widmark, et al.
Cancer Research|March 26, 2002
Osteoprotegerin (OPG) is a survival factor for human prostate cancer cellsIngunn Holen, Peter I Croucher, Freddie C Hamdy, et al.
BJU International|April 5, 2013
The emerging role of histone deacetylase (HDAC) inhibitors in urological cancersNaomi L Sharma, Blaz Groselj, Freddie C Hamdy, et al.
Pageof 27

Showing results (1-10 of 270) with videos related to

Sort By:
Pageof 27
European Urology|September 11, 2007
Screening for prostate cancer: an updateRichard J Bryant, Freddie C Hamdy
Expert Review of Anticancer Therapy|July 13, 2002
Staging in prostate cancerBeverley A Wilkinson, Freddie C Hamdy
Cancer Treatment Reviews|June 6, 2003
Early diagnosis and surgical management of prostate cancerKate D Linton, Freddie C Hamdy
Current Urology Reports|April 27, 2007
The spectrum of prostate cancer care: from curative intent to palliationAsed S M Ali, Freddie C Hamdy
Cancer Research|March 27, 2012
Mre11-dependent degradation of stalled DNA replication forks is prevented by BRCA2 and PARP1Songmin Ying, Freddie C Hamdy, Thomas Helleday
Future Oncology (London, England)|February 12, 2010
Targeting chemotherapy to advanced bladder cancer patients most likely to benefitJames W F Catto, Freddie C Hamdy
European Urology Focus|November 4, 2017
Reducing Mortality in the Ageing Patient: Treatment of the Primary Tumour Is Not NecessaryAlastair D Lamb, Simon F Brewster, Freddie C Hamdy
Acta Oncologica (Stockholm, Sweden)|May 25, 2011
Curative radiation therapy in prostate cancerUlrika Harmenberg, Freddie C Hamdy, Anders Widmark, et al.
Cancer Research|March 26, 2002
Osteoprotegerin (OPG) is a survival factor for human prostate cancer cellsIngunn Holen, Peter I Croucher, Freddie C Hamdy, et al.
BJU International|April 5, 2013
The emerging role of histone deacetylase (HDAC) inhibitors in urological cancersNaomi L Sharma, Blaz Groselj, Freddie C Hamdy, et al.
Pageof 27